DelveInsight Blogs Sitemap

All Posts in this category
S.No. Product Name Actions
1 Charcot-Marie-Tooth Disease Market Size Expects Growth Owing to Increasing Prevalence, Influx of Pharma Companies and Novel Therapies Visit Post
2 Top 7 Pharma Industry Leaders in 2020 By the Numbers Visit Post
3 Primary Hyperoxaluria Market Size Observes Growth with a Substantial CAGR Visit Post
4 Roadblocks In The Peripheral Nerve Injury Market Require A Multi-faceted Approach Visit Post
5 Cervical Cancer Market Has A Lot Going On Under The Hood Visit Post
6 New Hopes; New Horizons: Gastroparesis Market Has Mighty Treatment Options On Its Sleeves Visit Post
7 Celiac Disease: The Hidden Epidemic of Gluten Sensitivity Visit Post
8 Infectious Diseases That Possess Significant Challenge To Humans Health Visit Post
9 Medical Marijuana: Is it a blessing in disguise or a curse for humanity? Visit Post
10 Unfolding The Folds Of Transthyretin Visit Post
11 A Complex Chromosomal Abberation Called Adrenoleukodystrophy Visit Post
12 Addressing The Scattered Harbingers of Frontotemporal Dementia Visit Post
13 Rejections and Withdrawals: Familial Chylomicronemia Syndrome Market Needs a Therapy Effective Enough, Affordable Enough Visit Post
14 Watch Out for the Most Promising Therapies in the Pipeline in Acute Kidney Injury Market Visit Post
15 An Eye-Blinding Scenario of Vernal keratoconjunctivitis Visit Post
16 Metabolic Acidosis: Counting The Unmeasured Anions And Closing the Gap In Blood Serum Visit Post
17 Spot the Signs and Fight Postpartum Depressions Visit Post
18 Rising Nontuberculous Mycobacterial Infection Prevalence Poses A Major Public Health Concern Visit Post
19 Small Cell Lung Cancer Market Booms with an Influx of Companies and Robust Pipeline Visit Post
20 Top 5 Cancers Creating Major Challenge To The Global Healthcare System Visit Post
21 In Search for a Curative Treatment Option for Duchenne Muscular Dystrophy Visit Post
22 The Increasing Global Burden of Cytomegalovirus Seroprevalence Visit Post
23 Paradigm Shift In The Diabetic Peripheral Neuropathy Market Landscape As The Focus Shifts Towards The Cure Visit Post
24 The Question That Remains Unanswered: What Might Be Causing Alzheimer’s? Visit Post
25 How are Diabetic Peripheral Neuropathy medications changing the DPN market scenario? Visit Post
26 When Technological Innovations Help in Remembering for People Living with Alzheimer’s Visit Post
27 With the Advances in Regenerative Therapy to Offer Curated Treatment Options, Off-label Therapy Market is Set to Decline for Dilated Cardiomyopathy Visit Post
28 Prostate Cancer Market Experiences an Influx of the Pharma Players Veering the Market Ahead Visit Post
29 One of the leading causes of blindness, and a sight-threatening disease, Uveitis, now has novel treatment approaches in its pipeline Visit Post
30 Precision Medicine: An emerging approach to conventional treatment Visit Post
31 R&D and Upcoming therapies Paving the Way for a Potential and Better Cure for Immune Thrombocytopenia Visit Post
32 Hunter Syndrome Market experiences a positive push as the pharma companies spot the untapped opportunities Visit Post
33 Is the cure for Duchenne Muscular Dystrophy in the pipeline? Visit Post
34 Emerging Therapies that can significantly impact the Acute Kidney Injury Market Visit Post
35 Is the cure for Huntington’s disease on the horizon? Visit Post
36 Overcoming the prevailing unmet needs in Beta-Thalassemia Market Visit Post
37 Altering the course of Ovarian cancer with emerging therapies in the horizon Visit Post
38 Novel mutation-targeting therapies in the horizon to relieve the global healthcare burden NSCLC poses Visit Post
39 Chemotherapy Induced Febrile Neutropenia Market: High time to end the monopoly Visit Post
40 CAR-T cell therapy market for Non-Hodgkin lymphoma: Future prospects, and untapped opportunities Visit Post
41 Future Perspectives Of CAR-T Cell Therapy Market In Acute Lymphoblastic Leukemia (ALL) Visit Post
42 Warm Autoimmune Hemolytic Anemia: A less prevalent disease with prevailing unmet needs Visit Post
43 Warm Autoimmune Hemolytic Anemia Epidemiology forecast segmentation, treatment approaches, and WAIHA market forecast Visit Post
44 What is driving Retinitis pigmentosa market forward? Visit Post
45 Retinitis Pigmentosa: A complex disease, and the increasing gap between prevalence and diagnosed prevalence Visit Post
46 Soft Tissue Sarcoma Market size to increase with a CAGR of 6.47% – Emerging therapies and Increasing Incidence form major market drivers Visit Post
47 Soft Tissue Sarcoma: A rare malignancy Visit Post
48 Gene therapy might make cocaine less addictive Visit Post
49 Opioid Withdrawal Syndrome: What happens when a person withdraws from Opiates Visit Post
50 Cardiovascular Disease: A major cause of health loss and a global burden Visit Post
51 Wet Age-Related Macular Degeneration: Unravelling the complex disease with comprehensive R&D Visit Post
52 The epidemic now has a name: COVID-19 Visit Post
53 Bridging the gap: Nontuberculous mycobacterium Infections Drug Pipeline Visit Post
54 First-ever Peanut allergy treatment; Dinutuximab misses primary endpoint; Insmed's shares Soares Visit Post
55 Lack of effective therapy: A major Nontuberculous Mycobacteria Infection Market Driver Visit Post
56 Wuhan Coronavirus: A global emergency Visit Post
57 Thyroid awareness month Visit Post
58 Thyroid eye disease market: New therapies enter the TED market Visit Post
59 In a blind race to cure HIV, can Gene therapy be a deal-breaker? Visit Post
60 Malignant pleural mesothelioma market: Elusive treatment approaches and Poor diagnosis Visit Post
61 Egg Allergy Market: Second most common food allergy but no approved therapy Visit Post
62 Atopic dermatitis market: Increasing prevalence and topical treatments Visit Post
63 Allergic rhinitis market: How common is Hay fever? Visit Post
64 Global Allergic disease market Visit Post
65 Schizophrenia vs Bipolar disorder: Biomarkers to the rescue Visit Post
66 Increasing cases of Mania and Bipolar disorder market Visit Post
67 Fragile X Syndrome Market Visit Post
68 Gaucher disease Market Analysis: Rich Pipeline Drives the Market Ahead Visit Post
69 Are Rare Diseases truly Rare? Visit Post
70 Reblozyl under FDA review; Audentes buyout & Tecentriq’s new approval Visit Post
71 The Regulatory process for drug approval in the MENA region Visit Post
72 Chronic Refractory Cough Market landscape: A new approach to treating cough Visit Post
73 World AIDS Day- 2019 Visit Post
74 Alzheimer's Disease Market Infographic Visit Post
76 Novel treatment approval promises a better future for Sickle cell disease patients Visit Post
77 How Gene therapy is changing the Beta-thalassemia Treatment outlook? Visit Post
78 Antimicrobial resistance crisis: A global need for antibiotic awareness Visit Post
79 World COPD Day Visit Post
80 Parkinson’s Disease Market: Impact of Emerging therapies on Parkinson’s therapeutics market Visit Post
81 Non-Small Cell Lung Cancer Market: Treatments and Market Forecast Visit Post
82 Metastatic HER2-Positive Breast Cancer Infographic Visit Post
83 Emerging drugs bring a positive shift in Global Osteoporosis Market Visit Post
84 New Therapeutic advances that have shifted the Breast cancer market scenario Visit Post
85 HR-positive/ HER2-negative Breast Cancer Market Insights: Upcoming Therapies and Market Analysis Visit Post
86 FDA is reviewing a dangerous way to treat Peanut Allergy Visit Post
87 Allergic Conjunctivitis Therapy Market and Pipeline Analysis Visit Post
88 How Spinal Muscular Atrophy Therapies transform market? Visit Post
89 Leber Hereditary Optic Neuropathy Treatment Market Visit Post
90 Chemotherapy-Induced Peripheral Neuropathy Market Trends Visit Post
91 Is Parainfluenza virus contagious? Visit Post
92 Chronic Lower Back Pain Market Analysis Visit Post
93 Chronic Lower Back Pain Therapy Market Visit Post
94 Myasthenia gravis Market Outlook Visit Post
95 Chronic Lower Back Pain Visit Post
96 Post-Traumatic Stress Disorder Day Visit Post
97 Pompe Disease Treatment Market Visit Post
98 Pompe Disease Market Visit Post
99 What is the link between Alzheimer's and Menopause? Visit Post
100 Global Neuroendocrine Tumor Market Outlook Visit Post
101 Pulmonary Arterial Hypertension Therapies Visit Post
102 Unmet Needs in the treatment of Antitrypsin deficiency Visit Post
103 Acne Vulgaris Market Outlook Visit Post
104 Acute Bacterial Skin and Skin Structure Infections Emerging Therapies Visit Post
105 ABSSSI Current Therapeutic Market Visit Post
106 Spinal Muscular Atrophy: Current and Emerging Therapies Visit Post
107 Parkinson's Awareness Month 2019 Visit Post
108 Spinal Muscular Atrophy Market is expected to augment at a CAGR of 10.42% Visit Post
109 Autism Spectrum Disorder Visit Post
110 Global Parkinson’s Therapeutic Market Outlook Visit Post
111 Can commoners afford to spend million dollars on GENE Therapy? Visit Post
112 Beta Interferons prolongs life in Multiple Sclerosis Visit Post
113 New Osteoporosis Drug promises to rebuild Bone Visit Post
114 Gene Therapy in Oncology: Innovation to Commercialization Visit Post
115 Current and Emerging therapies that change Traveler’s Diarrhea Market Visit Post
116 Boys are more likely to have autism! Visit Post
117 Global Traveler's Diarrhea Market Visit Post
118 Rare Disease Day Visit Post
119 Cervical cancer Visit Post
120 Attention-Deficit/Hyperactivity Disorder (ADHD) Visit Post
122 Precautions for Breast Cancer Visit Post
123 Transthyretin Amyloidosis (ATTR) Competitive Landscape, Market Insights, Epidemiology and Market Visit Post
124 Nonalcoholic Steatohepatitis (NASH): Highly Epidemic Visit Post
125 Meeting the Unmet: Nonalcoholic Steatohepatitis (NASH) Visit Post
126 CRISPR to cure sickle cell; FDA rejected; Stem cells use; Celgene spinoff Visit Post
127 Immune Checkpoint Activators (ICA): Dynamic Therapeutic Targets Visit Post
128 Systemic Lupus Erythematosus (SLE) – Market Is Expected to Grow with Upcoming Therapies Visit Post
129 Celiac Disease (CD) – Upcoming therapies to break the stagnancy Visit Post
130 Natural Killer Cell Therapies– Advancing technology increasing competition among the companies Visit Post
131 Oral Mucositis – A Common Cancer Therapy Adverse Reaction Visit Post
132 Human Papillomavirus (HPV) Prophylaxis– Expected to see a steady growth from 2015-2025 Visit Post
133 Amyotrophic Lateral Sclerosis (ALS) a fatal disease! Visit Post
134 Progressive Supranuclear Palsy– A neurodegenerative disorder Visit Post
135 FDA grants accelerated approval to pembrolizumab Visit Post
136 Narcolepsy: Treatment options and market outlook Visit Post
137 Sarcopenia: “Aging-Associated Strength Loss Condition” Visit Post
138 Medical tourism in India Visit Post
139 Epidemiology: Fatty Liver Disease Visit Post
140 Colorectal Cancer Awareness Month Visit Post
141 Endometriosis : Understanding the complex disease Visit Post
142 Familial Adenomatous Polyposis (FAP): A cataclysmic genetic mutation Visit Post
143 Chronic Kidney Disease: Complex Debilitating Condition Visit Post
144 Cushing’s Syndrome: Cortisol Plethora Visit Post
145 Statistical Insight on Some Common Cancers Visit Post